Antibodies to β2-glycoprotein I: A potential marker for clinical features of antiphospholipid antibody syndrome in patients with systemic lupus erythematosus

Journal of Rheumatology

Volumn 25, Issue 11, 1998, Pages 2131-2134

  Sanfilippo, Sandro S ^a   Khamashta, Munther A ^a,c   Atsumi, Tatsuya ^a   Amengual, Olga ^a   Bertolaccini, Maria L ^a   D'Cruz, David ^b   Amft, Nicole ^b   Swana, Granville T ^c   Hughes, Graham R V ^a  

^a Rayne Institute

^b ROYAL LONDON HOSPITAL   (United Kingdom)

^c ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Antiphospholipid antibodies; Antiphospholipid syndrome; Hughes' syndrome; Thrombosis pregnancy loss

Indexed keywords

BETA2 GLYCOPROTEIN 1; CARDIOLIPIN ANTIBODY; DNA ANTIBODY; PHOSPHOLIPID ANTIBODY; ANTIBODY; ANTINUCLEAR ANTIBODY; BIOLOGICAL MARKER; DNA; GLYCOPROTEIN; IMMUNOGLOBULIN G;

ADULT; AGED; ANTIBODY DETECTION; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; B LYMPHOCYTE ACTIVATION; CLINICAL FEATURE; CORRELATION FUNCTION; DIAGNOSTIC VALUE; DISEASE MARKER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RISK FACTOR; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOLOGY; MALE; MIDDLE AGED;

ADULT; AGED; ANTIBODIES; ANTIBODIES, ANTICARDIOLIPIN; ANTIBODIES, ANTINUCLEAR; ANTIPHOSPHOLIPID SYNDROME; BETA 2-GLYCOPROTEIN I; BIOLOGICAL MARKERS; DNA; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GLYCOPROTEINS; HUMANS; IMMUNOGLOBULIN G; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; RISK FACTORS;

EID: 0031593936     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Hughes GRV. The antiphospholipid syndrome: ten years on. Lancet 1993;342:341-4.
2. Harris EN, Gharavi AE, Boey ML, et al. Anti-cardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet 1983;2:1211-4.
3. Harris EN, Gharavi AE, Patel BM, Hughes GRV. Evaluation of the anti-cardiolipin antibody test: report of an international workshop held 4 April 1986. Clin Exp Immunol 1987;68:215-22.
4. Cervera R, Khamashta MA, Font J, et al. Systemic lupus erythematosus: clinical and immunological patterns of disease expression in a cohort of 1000 patients. Medicine 1993;72:113-24.
5. Alarcon-Segovia D, Deleze M, Oria CV, et al. Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus. A prospective-analysis of 500 consecutive patients. Medicine 1989;68:353-65.
6. Love PE, Santoro SA. Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Ann Intern Med 1990;112:682-9.
7. Harris EN, Chan JKH, Asherson RA, Aber VR, Gharavi AE, Hughes GRV. Thrombosis, recurrent fetal loss, and thrombocytopenia. Predictive value of the anticardiolipin antibody test. Arch Intern Med 1986;146:2153-6.
8. Escalante A, Brey RL. Mitchell Jr BD, Dreiner U. Accuracy of anticardiolipin antibodies in identifying a history of thrombosis among patients with systemic lupus erythematosus. Am J Med 1995;98:559-65.
9. 2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface. J Exp Med 1994;179:457-62.
10. 2-glycoprotein I in the absence of phospholipid. J Immunol 1995;154:954-60.
11. 2-glycoprotein I and preserved during species' evolution. J Immunol 1996;157:5732-8.
12. 2-glycoprotein I in patients with antiphospholipid syndrome. Br J Rheumatol 1996;35:1239-43.
13. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
14. Harris EN. Antiphospholipid antibodies. Br J Haematol 1990;74:1-9.
15. Matsuura E, Igarashi Y, Fujimoto M, Ichikawa K, Koike T. Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease. Lancet 1990;336:177-8.
16. Galli M, Comfurius P, Maassen C, et al. Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor. Lancet 1990;335:952-3.
17. 2-glycoprotein I (apolipoprotein H). Proc Natl Acad Sci USA 1990;87:4120-4.
18. 2-glycoprotein assay for discrimination between anticardiolipin antibodies associated with infection and increased risk of thrombosis. Br J Haematol 1995;91:471-3.
19. 2-glycoprotein I. Arthritis Rheum 1994;37:1453-61.
20. 2-glycoprotein I and clinical manifestations in patients with systemic lupus erythematosus. Arthritis Rheum 1996;39:1466-74.
21. 2-glycoprotein I antibodies: a marker of antiphospholipid syndrome? Lupus 1995;4:122-30.
22. 2-glycoprotein I contains a phospholipid binding site (Cys281-Cys288) and a region recognized by anticardiolipin antibodies. J Immunol 1994;152:653-9.
23. 2-glycoprotein I antibodies: detection and association with thrombosis. Br J Haematol 1995;89:397-402.
24. 2-glycoprotein I than with antiphospholipid antibodies. J Rheumatol 1995;22:1899-906.
25. 2-glycoprotein-I in patients with primary antiphospholipid syndrome. J Rheumatol 1995;22:1894-8.
26. 2-glycoprotein I and a conventional anticardiolipin immunoassay. Arthritis Rheum 1996;39:1606-7.
27. 2-glycoprotein I antibodies and antiphospholipid syndrome. Internal Medicine 1996;35:105-10.